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Background: Human papillomavirus (HPV)-related anal cancer lesions are often found adjacent to the
squamocolumnar junction (SCJ). We have assessed the histopathology and associated HPV genotypes in anal
SCJ lesions in surgically excised anal warts in HIV-negative and –positive patients.
Methods: Histopathology identified 47 squamous intraepithelial lesions (SILs) adjacent to the SCJ amongst a
total of 145 cases of clinically diagnosed anal condylomata. The anal SCJ lesions were further analyzed with p16,
CK7 and p63 immunohistochemistry and HPV genotyping.
Results: Sixteen (16/47) of the excised anal wart lesions contained HSIL; Three were HSIL and exclusively
associated with oncogenic HPVs. A further thirteen (13/47) were mixed lesions. Of these eight were HSILs with
LSIL and six were HSILs with papillary immature metaplasia (PIM); Ten of the mixed lesions were associated
with one or more oncogenic HPVs, while three cases were exclusively associated with HPV6.
Conclusions: Clinically diagnosed anal warts cannot be assumed to be limited to low-grade lesions as anal warts
of the SCJ often show heterogeneous lesions, with coexistence of LSIL, PIM, and HSIL. Lesions showing PIM,
however, may mimic HSIL, because they are hypercellular, but lack the nuclear atypia and conspicuous mitotic
activity of HSIL; and are p16 negative.
1. Introduction
Anal cancer is a relatively rare disease in the general population,
with an incidence of 1–3% of all tumors of the digestive system [1,2].
Anal canal squamous intraepithelial lesions (SILs) caused by certain
human papillomaviruses (HPVs) play a fundamental role in anal
carcinogenesis [3–6]. Moreover, anal carcinoma and related precursor
lesions have been increasing in incidence in the last five decades by 2%
per year, for both men and women [2,3]. In agreement with the
proposed infectious etiology [7], anal cancer is especially common
among men who have sex with men (MSM), as well as in patients
infected by human immunodeficiency virus (HIV). HIV-positive MSM
show the highest risk of anal cancer [3,7,8]. Women with cervical and
vulvar cancer, and patients receiving immunosuppressive treatment
have also been demonstrated to have an increased risk of anal cancer
compared with the general population [3].
A two-faceted classification system for HPV-driven anogenital
lesions has been previously established: i) low-grade squamous in-
traepithelial lesions (LSILs) such as condylomata and not considered
cancer precursor lesions; and ii) high-grade squamous intraepithelial
lesions (HSILs) and considered cancer precursor lesions [9,10].
Interestingly, however, it has been shown that anogenital LSILs may
carry foci of HSIL [11–13]. The juxtaposition of multiple histopatho-
logical patterns is interpreted as the confluence of adjacent indepen-
dent lesions associated with independent HPV infections [13]. Such a
view, follows the logic of the possible clonal origin of warts introduced
by Murray and colleagues [14] and recently revisited as “one-virus,
one-lesion” [15]. This pattern of mixed histopathology in the same
lesion, often concurrent with the detection of multiple HPVs, is
especially common in immunocompromised patients [13,16]. Such
complex lesions among anal LSILs, containing a HSIL component,
pose a complex diagnostic problem [17,18].
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The microanatomy of anal mucosa includes transitional epithelia of
the squamocolumnar junction (SCJ), but in contrast to the uterus
cervix, with a unique population of stratified columnar cells covering
the single layered basal cells [18]. These two different cell types in the
anal transitional zone are not homogeneously susceptible to HPV-
driven carcinogenesis [18]. Indeed, previous findings suggest that an
abrasion of the columnar cells within the anal transition zone is
required to expose the basal cells for persistent HPV-infection and
further carcinogenic transformation [19].
The aim of this study was to histologically classify anal warts of the
SCJ among HIV-negative and –positive patients in accordance with the
LAST classification [9,10] and standard terminology [20] and to
associate the repertoire of HPV genotypes present within each SIL
type classification.
2. Materials and methods
2.1. Sample biopsies
This study was approved (09/24/2010) by the Human Research
Ethics Committee of Royal Perth Hospital (EC 2010/093) and the
IDIBELL - Bellvitge Biomedical Research Institute/ Catalan Institute of
Oncology as part of a retrospective review of HPV infections in
anogenital lesions. This study was done in accordance with the
Declaration of Helsinki, and written informed consent was obtained
from each patient prior to surgical treatment. A total of 145 formalin-
fixed paraffin embedded (FFPE) surgical anal canal lesion cases were
analyzed from non-HPV-vaccinated patients with known HIV status,
attending the Sexual Health Clinic at Royal Perth Hospital, Perth,
Australia, between 1995 and 2011 (Fig. 1). Biopsy cases were collected
from patients clinically identified with anal warts and who thus
required surgical excisional treatment to remove the warts. All patients
consented to surgery. Each FFPE sample was processed for histology
and for viral DNA analysis, using a sandwich sectioning technique as
previously reported [21].
2.2. Histopathology diagnosis and case selection
One-hundred and forty five biopsies of the anal canal were reviewed
by two pathologists (OC and VMM) using hematoxylin-eosin stained
sections. Forty-seven cases showing diagnostic features of SIL, and
involving the anal SCJ were selected for further histopathological
classification. The histological features of the anal SCJ were identified
using hematoxylin-eosin stained sections. To estimate the cellular
origin of the HPV-related anal SILs we used CK7 immunostaining to
identify CK7-positive SILs presumed to have arisen from SCJ columnar
cells or related progeny [18,22]. However, a note of caution is needed
as CK7 is not entirely a specific marker to evaluated the explicit SCJ
origin of the HPV-related anal or cervical lesions [18,22]. Alternatively,
cytokeratin 17 (CK17) and p63 have been suggested to be useful for
anal lesion immunohistopathology but these biomarkers are mainly
useful in cases of invasive anal squamous cell carcinomas and with
limited use in cases of anal SILs [23,24].
2.3. Histological classification in accordance with LAST
Criteria for LSIL [10,25]: LSILs were lesions with proliferative
squamous cells having abnormal nuclear features, including increased
nuclear size, irregular nuclear membranes, and increased nuclear to
cytoplasmic ratio. Lesions with little cytoplasmic maturation in the
lower third of the epithelium, and maturation observed in the middle
third and upper third of the epithelium. The presence of cytopathic
effect of HPV (i.e. koilocytosis) could also be observed, including
multinucleation, nuclear enlargement, and pleomorphism, accompa-
nied by perinuclear halos.
In addition, cases classified as LSIL, but showing areas of Papillary
Immature Metaplasia (PIM or "immature condyloma"), a distinct
pathological subtype of LSIL, were identified [26–30]. PIM is not
specifically addressed in the LAST classification, however, its recogni-
tion is important because it is a distinct subset of exophytic LSIL,
typically p16-negative, but with a potential to mimic HSIL, which is
recognized by the LAST [10,28]. PIM lesions showed papillae with thin
fibrovascular cores, lined by immature squamous cells, with only low
levels of mitosis in basal cells, and typically showing CK7 positive
columnar cells on the surface [26–30]. To further assess the mixed
population of columnar and basal squamous cells often found in PIM
lesions we performed p63 immunostaining, in addition with CK7, for
selected cases.
Criteria for HSIL [10,25]: Lesions with proliferative squamous cells
with abnormal nuclear features, including increased nuclear size,
irregular nuclear membranes, and increased nuclear to cytoplasmic
ratios accompanied by mitotic figures. Lesions with little or no
cytoplasmic maturation in the middle third and superficial third of
the epithelium. In HSILs mitotic figures were not confined to the lower
third of the epithelium, but were also found in the middle and/or
superficial third of the epithelium. The presence of HSIL was further
assessed with p16-positive IHC [31].
2.4. Immunohistochemistry
Immunohistochemical staining for CK7 and p16 biomarkers were
performed on 3 µm sections of FFPE specimens using primary rabbit
or mouse anti-human monoclonal antibody C clone SP52 for CK7
(Ventana Inc, US) and clone E6H4 for p16 (Ventana Inc, US) at a
dilution of 0.5 mg/mL or 1.0 mg/mL, respectively. Additional immu-
nohistochemical staining for p63 biomarker was perfomed using
mouse anti-human monoclonal antibody clone 4A4 (Ventana Inc,
US) at a dilution of 0.140 ng/mL. The staining was performed on a
Ventana Bechmark LT automated immunostainer (Ventana Medical
Systems Inc., Tucson, AZ) in accordance with standard protocols.
Overexpression for p16 was considered positive when immunostaining
was basal and ascending with strong nuclear and cytoplasmic positivity
(Fig. 2B). When the staining was absent, patchy or discontinuous it was
considered p16 negative (Fig. 2B). Expression of CK7 in multiple
contiguous cells was classified as positive while diffuse or patchy
staining was considered negative. Only nuclear staining for p63 was
considered positive (Fig. 2C).
2.5. HPV Genotyping
Total DNA was obtained from the FFPE samples as described [32]
using proteinase K incubation and inactivation. Sample DNA quality
and the presence of HPV DNA in the biopsies was further determined
using two different detection methods, SPF10-DEiA-LiPA25 and HSL-
PCR/Luminex systems as well as broad-papillomavirus PCR sequen-
cing as previously reported [22]. In this study we referred to HPVs as
oncogenic high-risk HPVs as classified by the International Agency for
Research on Cancer into carcinogenic or probably or possibly carcino-
genic agents, while HPVs commonly observed in anogenital infections
but not yet considered carcinogenic were referred to as non-oncogenic
Fig. 1. Schematic diagram of the 47 FFPE anal squamous intraepithelial lesion (SIL)
cases of the squamocolumnar junction (SCJ).




Data analysis using STATA (StataCorp, US) was performed on the
total of 47 anal SIL cases of the anal SCJ shown in Fig. 1. For
association analysis between histopathological categories and HPV
genotypes, a Fisher´s exact test with a significance level at 0.05 for
p-value was used. Prevalence ratios of the histopathological categories
and HPV genotypes between HIV-positive and –negative patients were
estimated using the Poisson regression model with robust variance.
3. Results
To characterize the histopathology and associated HPV infections in
anal SCJ lesions clinically diagnosed as genital warts we investigated
145 anal SIL cases previously reported [21] and shown in Fig. 1. From
the total of 47 clinically diagnosed anal warts, involving the anal canal
SCJ, 16 were diagnosed as HSIL and 31 as LSIL (Table 1).
Thirteen HSIL lesions combined features of LSIL (Figs. 1 and 2, see
also Supplementary Figs. 1 and 2), and five of these showed also PIM
(Fig. 3, see also Supplementary Figs. 3 and 4). PIM lesions adopted a
characteristic papillary growth pattern, while HSILs were flat (Fig. 3,
see also Supplementary Figs. 3–5). At least one high-risk HPV type was
identified in 13 HSILs, but three cases of mixed HSIL and LSIL were
exclusively associated with HPV6 (Table 1, Fig. 2, see also
Supplementary Fig. 3). Immunostaining of p16 was positive in the
corresponding areas of HSIL in 15 cases (Figs. 2B and 3B, see also
Supplementary Figs. 1–5), and negative in one case associated with
HPV52 and HPV91 (Fig. 4, see also Table 1). All 31 cases with LSIL,
including 12 with PIM (Fig. 5, see also Supplementary Figs. 6–10),
were p16 negative. Of 31 biopsies classified as LSIL or LSIL with PIM,
29 were associated with non-oncogenic HPVs, and two cases with at
least one oncogenic HPV (Table 1). CK7 showed positive immunos-
taining of columnar cells in all anal SCJ lesions likely arisen from SCJ
columnar cells or related progeny (Figs. 4D and 5D, see also
Supplementary Figs. 1,3,6–10). In addition, p63 biomarker showed
wide nuclear immunostaining of anal SCJ SILs (Figs. 2C, 3C and 4E,
see also Supplementary Figs. 2,4,5,8–10). Due to the demonstrated
changes in host immune response and the higher risk of HPV related
disease in HIV-infected patients [6] we further analyzed the data,
stratifying by HIV-status. A significant difference (P=0.011) between
HIV-negative and –positive patients was observed for the prevalence
values of different SIL categories, associated either with at least one
oncogenic or only with non-oncogenic HPVs (Table 2).
Anal SCJ LSILs with PIM and linked with non-oncogenic HPV
infection were more prevalent, although not significantly, in HIV-
negative (34.6%) compared with HIV-positive (4.8%) patients. In
contrast, anal SCJ LSILs with PIM and oncogenic HPV infection were
only seen in HIV-positive patients. Mixed anal SCJ HSIL with LSIL
cases associated with at least one oncogenic HPV were seen 2.3 times
more frequently in HIV –positives compared with HIV-negative cases
Fig. 2. SIL of the anal SCJ showing coexistence of LSIL and HSIL in a HIV-positive patient: A) Hematoxylin-eosin staining. LSIL is exophytic, while HSIL is limited to a flat area; B)
Strong and diffuse local p16 immunostaining in the HSIL component but only patchy staining in the LSIL component of the lesion; C) Nuclear p63 immunostaining. HPV genotyping
was positive for HPV6. Original magnification x4.
Table 1
Histopathology of the 47 anal squamous intraepithelial lesions (SILs) of the squamocolumnar junction.
LAST TYPE N % p16+ HPV genotypes
n high-risk HPV n low-risk HPV
HSIL 34% (16/
47)
HSIL 3 6.4 2/3 3/3 HPV16 (x2), HPV52-91 – –




23.1% (3/13) HPV6 (x2)
HSIL+LSIL
+PIM
5 10.6 5/5 HPV16, HPV6-16, HPV6-18, HPV11-52 HPV6
LSIL 66% (31/
47)
LSIL+PIM 12 25.5 0/12 16.7% (2/12) HPV6-18-40–43, HPV52 83.3% (10/
12)
HPV6 (x3), HPV6-43, HPV6-11, HPV11 (x5)
LSIL 19 40.4 0/7* – – 19/19 HPV6 (x9), HPV11 (x5), HPV6-11, HPV6-
44, HPV6-7, HPV6-74, HPV43
LAST, Lower Anogenital Squamous Terminology classification; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion. TYPE, lesion type
classified at microscopic level as HSIL or LSIL; HSIL+LSIL, LSIL with foci of HSIL; HSIL+LSIL+PIM, mixed HSIL and LSIL including focal papillary immature metaplasia (PIM); LSIL
+PIM, LSIL including focal PIM.
N, Number of cases; %, percentage of the lesion types; p16+, Number of positive p16 immunostaining cases in each category; HPV, Human Papillomavirus. In case of several samples
within the same LAST category showed exactly the same HPV types the number of cases is indicated in the parenthesis (e.g. HPV6 (2x)). * Only seven cases were further tested with
p16 immunostaining.
high-risk HPV, at least one oncogenic HPV type (i.e. HPV16, 18, 31, 34, 39, 45, 51, 52, 53, 56, 58) observed in the biopsy.
low-risk HPV, only non-oncogenic HPV types (i.e. HPV6, 11, 7, 40, 43, 44, 74, 91) observed in the biopsy.
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[95%CI: 1.10 – 4.50]. No trend with HIV co-infection was observed for
the prevalence of HSIL with LSIL mixed lesions associated exclusively
with non-oncogenic HPVs.
4. Discussion
The causal role of oncogenic HPVs in anal carcinogenesis, [6]
particularly within SCJ, [34] is regarded analogous to the development
of cervical cancer. [35] Persistent infection of oncogenic HPV in basal
cells of the SCJ induces the local development of SIL and typically
further carcinogenesis [36]. However, a recent study reveals significant
anatomical differences between cervical and anorectal SCJ associated
with HPV-related cancer risk [18]. In contrast to the single-layered
columnar cells covering the basal cells of the cervical SCJ, the anal SCJ
is lined by a multilayer of columnar cells. This difference between the
SCJs of anus and cervix have been proposed as potentially explaining
the 17-fold higher incidence of HPV-induced cervical cancers com-
pared with anal cancers worldwide [18]. However, regarding the HPV-
driven anal lesions, it is important to recall the correlation between the
type of SIL and the HPV type detected [9,10]. Clinically diagnosed
condylomata, the most common subtype of LSILs, are mostly induced
by non-oncogenic HPV types (mainly HPV6 or HPV11), and these
lesions are not considered significant precursors of anal cancer not
withstanding rare reports [10]. Conversely, HSILs (as well as many
LSILs) are induced by oncogenic HPV types. These lesions are
considered precursors of anal squamous cell carcinomas [6,9]. Earlier
studies, however, have shown that anal condyloma, considered a subset
of LSIL, [3] may also harbour foci of HSIL or even invasive carcinoma
[16]. Moreover, low-grade anal lesions can be caused by high-risk
HPVs and vice versa [21,37].
In this study, we found that 34.0% (16/47) of the clinically
diagnosed anal warts of the SCJ were HSILs by histopathology, and
76.9% (13/16) of these HSILs were combined with LSIL. This is in line
with previous studies of cervical and vulvar intraepithelial lesions
showing that an extensive exophytic growth of low-grade lesions may
obscure an adjacent/mixed high-grade lesion [11–13]. Moreover, we
Fig. 3. SIL of the anal SCJ showing coexistence of PIM, LSIL and HSIL in a HIV-positive patient: A) Hematoxylin-eosin staining; B) Strong and diffuse local p16 immunostaining
limited to HSIL component of the lesion; C) Strong nuclear p63 immunostaining. HPV genotyping was positive for HPV6 and HPV16. Original magnification x4.
Fig. 4. HSIL of the anal SCJ showing increased cellularity, and loss of surface maturation: A) Hematoxylin-eosin staining with 10 x original magnification; B) Higher magnification
showing increased nuclear-cytoplasmic ratio and abnormal mitosis. Hematoxylin-eosin staining with 40 x original magnification; C) Negative p16 immunostaining, 20 x original
magnification; D) Positive CK7 immunostaining, 40 x original magnification; E) Nuclear p63 immunostaining, 40 x original magnification. HPV genotyping was positive for HPV52 and
HPV91.
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found that five of these cases containing both LSIL and HSIL contained
also focal PIM. The association is of interest for two reasons. First, PIM
has been previously reported to be a unique subset of exophytic LSIL,
also been termed "immature condyloma", but with a potential to mimic
HSIL [26–30]. In addition, PIM has been reported in association with
HSIL. Second, PIM in the cervix is assumed to arise via infection of
immature metaplastic epithelium with low-risk HPVs [27,30]. Similar
lesions can also be found near the urethra, manifesting with a
transitional phenotype that may prompt the diagnosis of "transitional
papilloma". Their frequent finding in the anus is of interest in as much
as their presence there could signify infection of the immature
squamous cells near the anal SCJ.
Taking into account the unique nature of the anal transformation
zone and the fact that many of these patients are immunosuppressed, it
is not unexpected that biopsies of anal warts of the SCJ are frequently
heterogeneous, combining features of LSIL, including PIM, and HSIL
in 27.6% (13/47) of the cases in this study. This heterogeneity was
confirmed through p16 immunohistochemistry (IHC), showing over-
expression limited to HSIL, and areas of LSIL and PIM being p16-
negative (see Fig. 3). However, a note of caution is needed in the use of
adjunct p16 IHC as according to LAST [11] 10–20% of less developed
HSILs can be p16 negative. Indeed, in our study we observed one HSIL
with p16 negative IHC (Fig. 4), but as recommended by LAST [10],
histopathology diagnosis was not downgraded. In addition, lesions with
PIM, often hypercellular and showing a mixed population of columnar
and basal squamous cells, previously described in cervix and anus,
[27–30,38] are of special interest in the study of anal warts due to their
potential mimicry of HSIL. This in turn might further lead to failure in
diagnosing clinically more important high-grade lesions, or overclassi-
fying HSIL by failure to recognize PIM.
In this study, we identified a good concordance between the
histological diagnosis of anal HSIL and the detection of oncogenic
HPV types. All HSIL biopsies and 76.9% (10/13) of the mixed HSIL
with LSIL cases were associated with oncogenic HPV infection.
However, in three cases the diagnosis of focal HSIL, also with p16
positivity, was exclusively associated with HPV6. This is an interesting
observation as some studies suggest that p16 expression with HPV6
Fig. 5. SIL of the anal SCJ showing LSIL, and contiguous area of PIM: A) SIL of the anal SCJ showing LSIL, and contiguous area of PIM. Original magnification x4; B) The area of PIM is
densely cellular compared with LSIL. Original magnification x10; C) Negative p16 immunostaining, 20 x original magnification; D) PIM showing papillae with thin fibrovascular cores
lined by stratified epithelium with columnar cells on the surface. Significant nuclear atypia or mitotic activity was not observed. Original magnification x20; E) Columnar cells on the
surface of papillae were CK7 positive. Original magnification x20. HPV genotyping was positive for HPV6.
Table 2
Prevalence contribution of anal squamous intraepithelial lesions (SILs) of the
squamocolumnar junction and associated oncogenic/non-oncogenic HPV infections in










LSIL LSIL and LR HPVs 12 (46.2) 7 (33.3) Ref. –
LSIL+PIM and LR
HPVs
9 (34.6) 1 (4.8) 0.3 0.04–1.95
LSIL+PIM and HR
HPV





1 (3.9)* 2 (9.5) 1.8 0.66–4.94
HSIL+LSIL and HR
HPV
1 (3.9) 5 (23.8) 2.3 1.1–4.5
HSIL+LSIL+PIM
and HR HPV
2 (7.7) 2 (9.5) 1.4 0.43–4.31
HSIL HSIL and HR HPV 1 (3.9) 2 (9.5) 1.8 0.66–4.94
Fisher exact test p-value 0.011
Wald test p-value < 0.002
Prevalence ratio (PR) and 95% confidence interval (CI) for robust Poisson multivariate
regression model. One multinomial variable with seven categories were used to evaluate
the associations between lesion type, oncogenic HPVs and HIV-status of the patient.
LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intrae-
pithelial lesion; LSIL+PIM, LSIL with focal PIM; HSIL+LSIL+PIM, mixed HSIL and
LSIL with a focal PIM. LR HPVs, only non-oncogenic low-risk HPVs; HR HPVs, at least
one oncogenic high-risk HPV observed in the case. HIV-, HIV-negative; HIV+, HIV-
positive. LSILs with only low-risk HPVs was used as reference group (Ref) in the
multinomial variable. Oncogenic high-risk HPV types observed in this study are
presented in Table 1. *This sample also presented focal PIM.
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may not always occur [39]. In accord, it has been demonstrated that
non-oncogenic HPV6 or HPV11 infections can also be exclusively
associated with anogenital HSIL and squamous carcinoma [40–42].
These results may indicate a role of HPV6 associated with malignant
transformations of the anal SCJ. Finally, our cases showing LSIL and
PIM (N=12), without HSIL, were associated with non-oncogenic HPV6
or HPV11, although, oncogenic HPV types were detected in two cases.
These evidence, however, needs to be treated with caution as no further
analysis were performed to identify the transcriptionally active HPV
type within a particular anal lesion component.
Although the use of p16 immunostaining to predict HSIL is limited
in the cervix by the multiplicity of high risk HPV types found with low-
grade morphologies, p16 staining was particularly helpful in sorting
out lesions combining both low and high risk HPVs in the anal SCJ,
especially in the case of PIM (Fig. 3, see also Supplementary Figs. 3 and
4). Additional biomarkers CK7 and p63 were also helpful in identifying
the mixed population of columnar and basal squamous cells respec-
tively often found in PIM lesions (see Supplementary Fig. 10).
However, these biomarkers were only of additional use for the
histopathological distinction between HSIL and PIM.
Simultaneous infection with several oncogenic and/or non-onco-
genic HPVs is commonly observed in lower genital tract SILs,
especially among HIV-positive patients [6,13,16]. In agreement, we
observed that more than half of the anal SCJ mixed LSIL with HSIL
histology lesions showed the presence of at least two different HPV
infections, mainly in HIV-infected patients. These result may further
suggest that focal HSIL mixed with LSIL and/or PIM might be
independent lesions caused by independent HPV infections, in accor-
dance with the clonal etiology of HPV-induced lesions [14,15].
Nevertheless, we are aware that our study is limited regarding the
distinction between transcriptionally active HPVs and HPVs only
present at the DNA level in cases associated with multiple HPVs
infections. Moreover, with the current data, we can not specify for
certainty if a particular HPV DNA is present only in a specific lesion
component (i.e. HSIL/LSIL/PIM) in multiple HPV-infected mixed-
lesion cases. Future work using a larger data set and also with RNA-
level viral detection combined with laser capture microdissection
would allow to detect the precise presence of transcriptionally active
HPVs in different anal lesions of the SCJ, and thus, more accurately
evaluate their connection with anal cancer development.
In summary excised anal lesions of the SCJ often were hetero-
geneous; with coexistence of LSIL, including PIM, and HSIL. The
recognition of PIM, considered an immature variant of exophytic
condyloma, was particularly important given its frequent association
with low risk HPVs on one hand and its potential for being confused
with or coexisting with HSILs. Our results also showed that mixed anal
HSIL with LSIL lesions of the SCJ were at least twice more common in
HIV-infected than in HIV-negative patients. The presence of low-risk
HPV6 alone in cases of HSIL is of uncertain significance. However, rare
anogenital HSILs and squamous carcinomas have been reported with
HPV6 infection alone and such uncommon associations may bear
further study (Huang E, Howitt B, Crum, CP, personal communica-
tion). Taken together that the SCJ is particularly susceptible to HPV
infections in the cervix [36] and to a some extent in the anus [19]
further indicates that this transitional epithelia retains a unique role in
the development of SIL and cancer risk in connection to anal HPV
infections. In biopsies of SIL in or around the anal SCJ, histology, p16
IHC, and HPV genotyping are helpful in assigning a precise classifica-
tion and grade, particularly given the frequency of multiple infections
and phenotypes seen in immunosuppressed individuals. These results
indicate that a clinical diagnosis of anal warts in patients requiring
surgical excision treatment cannot be assumed to be limited to low-
grade lesions, and microscopic examination of anal wart tissue is
encouraged, especially among anal cancer high-risk groups, with
appropriate immunostains when the histologic picture is ambiguous.
Author contribution
Conceived the project: OC and VNP. Performed clinical diagnosis,
tissue sampling and collected patient information: JM. Performed
histopathology analysis and interpretation: OC VMM. Generated HPV
data and performed the analysis: VNP. Contributed to the study design
and data interpretation: JM VMM BQ IGB SS XFB. Supervised the
project and wrote the manuscript: VNP. All authors assisted in the
writing of the manuscript and had final approval of the submitted and
published versions.
Funding
This research was financially supported by The European Society of
Clinical Microbiology and Infectious Diseases (ESCMID Research
Grant 2015 VNP), the late Spanish Ministry for Science and
Innovation (Grant CGL2010-16713), Spanish Ministry for Economy
and Competitivity (PFIS Grant FI12/0142; FIS Grant PI11/02096),
and the Red Temática de Investigación Cooperativa en Cáncer (RTICC
Grant RD06/0020/0095). None of these agencies had any role in the
interpretation of the results, nor in the preparation of this manuscript.
Acknowledgements
The authors want to thank the patients willing to participate in the
study, as well as Cecily Metcalf and Dugald McCallum for reporting on
the original specimens in Australia. Laura Pallares, Richard Darwin,
Gemma Florensa, Jo-Ellen Klaustermeyer, Marleny Vergara, Yolanda
Florencia and Vanessa Camón are warmly thanked for technical
support as well as Laia Alemany is greatly thanked for helpful
comments of the manuscript. Silvia de Sanjose has received occasional
travel grants from Merck and Qiagen. F. Xavier Bosch is on the
Advisory Board (Merck and Co., Inc.); Speakers Bureau
(GlaxoSmithKline); and has received Institutional Research Grants
(Merck and Co., Inc., Sanofi Pasteur MSD, GlaxoSmithKline) not
related to the study presented. Finally, the authors are indebted to
Christopher Crum for his helpful review of the manuscript.
Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at doi:10.1016/j.pvr.2016.12.001.
References
[1] J.K. Greenson, ed., Diagnostic Pathology Gastrointestinal, First Ed., Amirsys, Salt
Lake City, Utah, 2010.
[2] L.G. Johnson, M.M. Madeleine, L.M. Newcomer, S.M. Schwartz, J.R. Daling, Anal
cancer incidence and survival: the surveillance, epidemiology, and end results
experience, 1973–2000, Cancer 101 (2004) 281–288. http://dx.doi.org/10.1002/
cncr.20364.
[3] J.M. Palefsky, A.R. Giuliano, S. Goldstone, E.D. Moreira, C. Aranda, H. Jessen,
R. Hillman, D. Ferris, F. Coutlee, M.H. Stoler, J.B. Marshall, D. Radley, S. Vuocolo,
R.M. Haupt, D. Guris, E.I.O. Garner, HPV vaccine against anal HPV infection and
anal intraepithelial neoplasia, N. Engl. J. Med. 365 (2011) 1576–1585. http://
dx.doi.org/10.1056/NEJMoa1010971.
[4] C. Fenger, P. Bichel, Flow cytometric DNA analysis of anal canal epithelium and
ano-rectal tumours, Acta Microbiol. Scand. A 89 (1981) 351–355 〈http://www.
ncbi.nlm.nih.gov/pubmed/7315332〉 (accessed 09.09.14).
[5] L. Abramowitz, D. Benabderrahmane, P. Ravaud, F. Walker, C. Rioux, C. Jestin,
E. Bouvet, J.-C. Soulé, C. Leport, X. Duval, Anal squamous intraepithelial lesions
and condyloma in HIV-infected heterosexual men, homosexual men and women:
prevalence and associated factors, AIDS 21 (2007) 1457–1465. http://dx.doi.org/
10.1097/QAD.0b013e3281c61201.
[6] J.M. Berry, N. Jay, R.D. Cranston, T.M. Darragh, E.A. Holly, M.L. Welton,
J.M. Palefsky, Progression of anal high-grade squamous intraepithelial lesions to
invasive anal cancer among HIV-infected men who have sex with men, Int. J.
Cancer 134 (2014) 1147–1155. http://dx.doi.org/10.1002/ijc.28431.
[7] C. Fenger, V.T. Nielsen, Intraepithelial neoplasia in the anal canal. The appearance
and relation to genital neoplasia, Acta Pathol. Microbiol. Immunol. Scand. A. 94
(1986) 343–349.
[8] F. Bosman, F. Carneiro, R. Hruban, N. Theise, WHO Classification of Tumours of
O. Clavero et al. Papillomavirus Research 3 (2017) 11–17
16
the Digestive System, Fourth ed., IARC Press, WHO, 2010.
[9] D.W. Northfelt, P.S. Swift, J.M. Palefsky, Anal neoplasia. pathogenesis, diagnosis,
and management, Hematol. Oncol. Clin. North Am. 10 (1996) 1177–1187 〈http://
www.ncbi.nlm.nih.gov/pubmed/8880204〉 (accessed 14.10.14).
[10] T.M. Darragh, T.J. Colgan, J. Thomas Cox, D.S. Heller, M.R. Henry, R.D. Luff,
T. McCalmont, R. Nayar, J.M. Palefsky, M.H. Stoler, E.J. Wilkinson, R.J. Zaino,
D.C. Wilbur, The lower anogenital squamous terminology Standardization project
for HPV-associated lesions: background and consensus recommendations from the
College of American Pathologists and the American Society for Colposcopy and
cervical pathology, Int. J. Gynecol. Pathol. 32 (2013) 76–115. http://dx.doi.org/
10.1097/PGP.0b013e31826916c7.
[11] J. Park, D. Sun, D.R. Genest, P. Trivijitsilp, I. Suh, C.P. Crum, Coexistence of low
and high grade squamous intraepithelial lesions of the cervix: morphologic
progression or multiple papillomaviruses?, Gynecol. Oncol. 70 (1998) 386–391.
http://dx.doi.org/10.1006/gyno.1998.5100.
[12] T. Agorastos, D. Miliaras, A.F. Lambropoulos, S. Chrisafi, A. Kotsis, A. Manthos,
J. Bontis, Detection and typing of human papillomavirus DNA in uterine cervices
with coexistent grade I and grade III intraepithelial neoplasia: biologic progression
or independent lesions?, Eur. J. Obstet. Gynecol. Reprod. Biol. 121 (2005) 99–103.
http://dx.doi.org/10.1016/j.ejogrb.2004.11.024.
[13] K.P. Maniar, B.M. Ronnett, R. Vang, A. Yemelyanova, Coexisting high-grade vulvar
intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions
due to different HPV types occurring in immunocompromised patients, Am. J.
Surg. Pathol. 37 (2013) 53–60. http://dx.doi.org/10.1097/
PAS.0b013e318263cda6.
[14] R.F. Murray, J. Hobbs, B. Payne, Possible clonal origin of common warts (Verruca
vulgaris), Nature 232 (1971) 51–52. http://dx.doi.org/10.1038/232051a0.
[15] W. Quint, D. Jenkins, A. Molijn, L. Struijk, M. van de Sandt, J. Doorbar, J. Mols,
C. Van Hoof, K. Hardt, F. Struyf, B. Colau, One virus, one lesion–individual
components of CIN lesions contain a specific HPV type, J. Pathol. 227 (2012)
62–71. http://dx.doi.org/10.1002/path.3970.
[16] T.A. Longacre, C.S. Kong, M.L. Welton, Diagnostic problems in anal pathology,
Adv. Anat. Pathol. 15 (2008) 263–278. http://dx.doi.org/10.1097/
PAP.0b013e318183234b.
[17] J.M. Palefsky, T.M. Darragh, Classification of anal squamous intraepithelial lesions,
Pathol. Case Rev. 18 (2013) 200–208. http://dx.doi.org/10.1097/
PCR.0b013e318298dfa0.
[18] E.J. Yang, M.C. Quick, S. Hanamornroongruang, K. Lai, L.A. Doyle, F.D. McKeon,
W. Xian, C.P. Crum, M. Herfs, Microanatomy of the cervical and anorectal
squamocolumnar junctions: a proposed model for anatomical differences in HPV-
related cancer risk, Mod. Pathol. 28 (2015) 994–1000. http://dx.doi.org/10.1038/
modpathol.2015.54.
[19] J.N. Roberts, C.B. Buck, C.D. Thompson, R. Kines, M. Bernardo, P.L. Choyke,
D.R. Lowy, J.T. Schiller, Genital transmission of HPV in a mouse model is
potentiated by nonoxynol-9 and inhibited by carrageenan, Nat. Med. 13 (2007)
857–861. http://dx.doi.org/10.1038/nm1598.
[20] J.C. Andrews, F. Bogliatto, H.W. Lawson, J. Bornstein, Speaking the Same
Language: Using Standardized Terminology, J. Low. Genit. Trac. Dis. 20 (2016)
8–10. http://dx.doi.org/10.1097/LGT.0000000000000157.
[21] V.N. Pimenoff, M. Félez-Sánchez, S. Tous, O. Clavero, J.M. Godínez,
J. Klaustermeier, M. Saunier, A. Molijn, L. Alemany, W. Quint, F.X. Bosch, S. de
Sanjosé, J. McCloskey, I.G. Bravo, Disagreement in high-grade/low-grade intrae-
pithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for
anal cancer precursor lesions in HIV-positive and HIV-negative MSM, Clin.
Microbiol. Infect. 21 (2015) e11–e19.
[22] E.C. Huang, M.M. Tomic, S. Hanamornroongruang, E.E. Meserve, M. Herfs,
C.P. Crum, P16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome
for low-grade squamous intraepithelial lesions: a case series, literature review and
commentary, Mod. Pathol. (2016). http://dx.doi.org/10.1038/mod-
pathol.2016.141.
[23] S.R. Owens, J.K. Greenson, Immunohistochemical staining for p63 is useful in the
diagnosis of anal squamous cell carcinomas, Am. J. Surg. Pathol. 31 (2007)
285–290. http://dx.doi.org/10.1097/01.pas.0000213362.10756.d3.
[24] R.M. Nazarian, A. Primiani, L.A. Doyle, K.R. Linskey, L.M. Duncan, R.D. Odze,
L.R. Zukerberg, Cytokeratin 17: an adjunctive marker of invasion in squamous
neoplastic lesions of the anus, Am. J. Surg. Pathol. 38 (2014) 78–85. http://
dx.doi.org/10.1097/PAS.0000000000000111.
[25] R.J. Kurman, Tumors of the cervix, vagina and vulva. AFIP Atlas of Tumor
Pathology, 1st ed, The American Registry of Pathology in collaboration with the
Armed Forces Institute of Pathology, Washinton, DC, 2010.
[26] G.H. Kang, K. Min, Y.H. Shim, K.R. Kim, Papillary immature metaplasia of the
uterine cervix: a report of 5 cases with an emphasis on the differential diagnosis
from reactive squamous metaplasia, high-grade squamous intraepithelial lesion
and papillary squamous cell carcinoma, J. Korean Med. Sci. 16 (2001) 762–768
〈http://www.ncbi.nlm.nih.gov/pubmed/11748359〉.
[27] C.-W. Liang, M.-C. Lin, C.-H. Hsiao, Y.-T. Lin, K.-T. Kuo, Papillary squamous
intraepithelial lesions of the uterine cervix: human papillomavirus-dependent
changes in cell cycle expression and cytologic features, Hum. Pathol. 41 (2010)
326–335. http://dx.doi.org/10.1016/j.humpath.2009.05.015.
[28] J.M. Roberts, A.M. Cornall, D. Ekman, C. Law, I.M. Poynten, F. Jin, R.J. Hillman,
D.J. Templeton, S.N. Tabrizi, S.M. Garland, J.K. Thurloe, A.E. Grulich,
A. Farnsworth, Papillary immature metaplasia of the anal canal: a low-grade lesion
that can mimic a high-grade lesion, Am. J. Surg. Pathol. (2015).
[29] T. Darragh, N. Jay, M. Berry, M.D. Costa, M. Ralston, E. Holly, J. Palefsky,
Papillary lesions of the anal canal, J. Low. Genit. Trac. Dis. 3 (1999) 36.
[30] B.E. Ward, A.M. Saleh, J.V. Williams, J.C. Zitz, C.P. Crum, Papillary immature
metaplasia of the cervix: a distinct subset of exophytic cervical condyloma
associated with HPV-6/11 nucleic acids, Mod. Pathol. 5 (1992) 391–395 〈http://
www.ncbi.nlm.nih.gov/pubmed/1323109〉.
[31] R. Bala, B.A. Pinsky, A.H. Beck, C.S. Kong, M.L. Welton, T.A. Longacre, p16 is
superior to ProEx C in identifying high-grade squamous intraepithelial lesions
(HSIL) of the anal canal, Am. J. Surg. Pathol. 37 (2013) 659–668. http://
dx.doi.org/10.1097/PAS.0b013e31828706c0.
[32] J.M. Godínez, S. Nicolás-Párraga, V.N. Pimenoff, B. Mengual-Chuliá, N. Muñoz,
F.X. Bosch, G.I. Sánchez, J. McCloskey, I.G. Bravo, Phylogenetically related,
clinically different: human papillomaviruses 6 and 11 variants distribution in
genital warts and in laryngeal papillomatosis, Clin. Microbiol. Infect. 20 (2014)
406–413. http://dx.doi.org/10.1111/1469-0691.12420.
[33] IARC, Human papillomaviruses, IARC Monogr. Eval. Carcinog. Risks Hum. 90
(2007) pp. 1–636.
[34] H. Fritsch, S. Zehm, R. Illig, P. Moser, F. Aigner, New insights into the development
and differentiation of the human anorectal epithelia. Are there clinical conse-
quences?, Int. J. Colorectal Dis. 25 (2010) 1231–1242. http://dx.doi.org/10.1007/
s00384-010-0986-6.
[35] F.X. Bosch, A. Lorincz, N. Muñoz, C.J.L.M. Meijer, K.V. Shah, The causal relation
between human papillomavirus and cervical cancer, J. Clin. Pathol. 55 (2002)
244–265.
[36] M. Herfs, Y. Yamamoto, A. Laury, X. Wang, M.R. Nucci, M.E. McLaughlin-Drubin,
K. Münger, S. Feldman, F.D. McKeon, W. Xian, C.P. Crum, A discrete population of
squamocolumnar junction cells implicated in the pathogenesis of cervical cancer,
Proc. Natl. Acad. Sci. USA 109 (2012) 10516–10521. http://dx.doi.org/10.1073/
pnas.1202684109.
[37] M.L. Siegenbeek van Heukelom, O. Richel, H.J.C. de Vries, M.M. van de Sandt,
S. Beck, H.A.M. van den Munckhof, E.C. Pirog, M.N.C. de Koning, J.M. Prins,
K.D. Quint, Low- and high-risk human papillomavirus genotype infections in intra-
anal warts in HIV-positive men-who-have-sex-with-men, Br. J. Dermatol. (2016).
http://dx.doi.org/10.1111/bjd.14567.
[38] P. Trivijitsilp, R. Mosher, E.E. Sheets, D. Sun, C.P. Crum, Papillary immature
metaplasia (immature condyloma) of the cervix: a clinicopathologic analysis and
comparison with papillary squamous carcinoma, Hum. Pathol. 29 (1998) 641–648.
[39] T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, T. Nakajima, Expression status of
p16 protein is associated with human papillomavirus oncogenic potential in
cervical and genital lesions, Am. J. Pathol. 153 (1998) 1741–1748. http://
dx.doi.org/10.1016/S0002-9440(10)65689-1.
[40] A.M. Cornall, J.M. Roberts, S.M. Garland, R.J. Hillman, A.E. Grulich, S.N. Tabrizi,
Anal and perianal squamous carcinomas and high-grade intraepithelial lesions
exclusively associated with “low-risk” HPV genotypes 6 and 11, Int. J. Cancer 133
(2013) 2253–2258. http://dx.doi.org/10.1002/ijc.28228.
[41] N. Guimerà, B. Lloveras, J. Lindeman, L. Alemany, M. van de Sandt, M. Alejo,
G. Hernandez-Suarez, I.G. Bravo, A. Molijn, D. Jenkins, A. Cubilla, N. Muñoz, S. de
Sanjose, F.X. Bosch, W. Quint, The occasional role of low-risk human papilloma-
viruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture
microdissection/PCR methodology: results from a global study, Am. J. Surg.
Pathol. 37 (2013) 1299–1310. http://dx.doi.org/10.1097/
PAS.0b013e31828b6be4.
[42] N. Guimerà, B. Lloveras, L. Alemany, E. Iljazovic, H.-R. Shin, S. Jung-Il, S. de
Sanjose, D. Jenkins, F.X. Bosch, W. Quint, Laser capture microdissection shows
HPV11 as both a causal and a coincidental infection in cervical cancer specimens
with multiple HPV types, Histopathology 63 (2013) 287–292. http://dx.doi.org/
10.1111/his.12137.
O. Clavero et al. Papillomavirus Research 3 (2017) 11–17
17
